Ranking of treatments according to P-scores for each
outcome. Coloured bars show the surface under the cumulative ranking
curve values for each endpoint. Higher bars correspond to higher surface
under the cumulative ranking curve and indicate better performing
treatments. P-scores range between 0 and 1: the higher
the P-score value, the higher the likelihood that a
therapy is more effective or safe. major adverse cardiovascular events:
1° = guided (0.931), 2° = prasugrel (0.673),
3° = clopidogrel (0.199), and 4° =
ticagrelor (0.198); all bleeding: 1° = clopidogrel
(0.983), 2° = guided (0.569), 3° = prasugrel
(0.233), and 4° = ticagrelor (0.214); all death: 1°
= guided (0.764), 2° = ticagrelor (0.756),
3° = prasugrel (0.411), and 4° = clopidogrel
(0.069); cardiovascular death: 1° = ticagrelor (0.771),
2° = guided (0.650), 3° = prasugrel (0.512),
and 4° = clopidogrel (0.066); myocardial infarction:
1° = guided (0.983), 2° = prasugrel (0.669),
3° = ticagrelor (0.337), and 4° =
clopidogrel (0.011); stent thrombosis: 1° = prasugrel
(0.930), 2° = guided (0.633), 3° =
ticagrelor (0.428), and 4° = clopidogrel (0.009); stroke:
1° = guided (0.891), 2° = prasugrel (0.574),
3° = clopidogrel (0.472), and 4° =
ticagrelor (0.063); major bleeding: 1° = clopidogrel
(0.779), 2° = guided (0.701), 3° =
ticagrelor (0.413), and 4° = prasugrel (0.088); minor
bleeding: 1° = clopidogrel (0.889), 2° =
guided (0.776), 3° = ticagrelor (0.200), and 4°
= prasugrel (0.136). *, best treatment.